Home / Health / Runner Denied Vital Drug, Faces $18K Hospital Bill
Runner Denied Vital Drug, Faces $18K Hospital Bill
30 Jun
Summary
- Senior runner denied essential medication due to prior authorization.
- Insurance denials led to costly hospitalizations for the runner.
- Appeals process can overturn denials, but is exhausting for patients.
Margaret Hvatum, a 70-year-old athlete with a compromised immune system, recently experienced severe health issues after her Medicare Advantage plan, Humana, denied prior authorization for her essential medication, Hizentra. This denial, which occurred in January 2026, led to missed doses and a subsequent urinary tract infection, resulting in an $18,000 hospital bill, which was also initially denied.
Medicare Advantage plans reviewed almost 53 million prior authorization requests in 2024, a process where insurers must approve treatments before they are administered. While Hvatum eventually appealed and secured approval for her medication, the process was frustrating and led her to switch drugs. She and her husband are now considering a move to Norway for universal healthcare.
Data shows that a significant majority, 81%, of Medicare Advantage appeals are overturned, yet the process is often too exhausting for patients. Hvatum's experience underscores the challenges seniors face with private insurance plans that prioritize profit by denying care, prompting discussions about systemic healthcare reform.
